Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081099 | SCV000113007 | benign | not specified | 2014-02-11 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514490 | SCV000609976 | likely benign | not provided | 2017-06-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316244 | SCV000851838 | benign | Inborn genetic diseases | 2017-06-27 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000514490 | SCV001019065 | benign | not provided | 2025-01-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000514490 | SCV005210533 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000514490 | SCV001798974 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000514490 | SCV001927929 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000514490 | SCV001964649 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003925064 | SCV004743962 | likely benign | FGD1-related disorder | 2020-02-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |